HUT47850A - Process for producing pharmaceuticals against hyperlipaemia and atherosclerosis - Google Patents
Process for producing pharmaceuticals against hyperlipaemia and atherosclerosisInfo
- Publication number
- HUT47850A HUT47850A HU88723A HU72388A HUT47850A HU T47850 A HUT47850 A HU T47850A HU 88723 A HU88723 A HU 88723A HU 72388 A HU72388 A HU 72388A HU T47850 A HUT47850 A HU T47850A
- Authority
- HU
- Hungary
- Prior art keywords
- atherosclerosis
- hyperlipaemia
- pyridoxamine
- pyridoxal
- pyridoxine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873705549 DE3705549A1 (de) | 1987-02-18 | 1987-02-18 | Verwendung von pyridoxin-derivaten bei der prophylaxe und therapie von hyperlipidaemien und atherosklerose |
Publications (1)
Publication Number | Publication Date |
---|---|
HUT47850A true HUT47850A (en) | 1989-04-28 |
Family
ID=6321453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU88723A HUT47850A (en) | 1987-02-18 | 1988-02-16 | Process for producing pharmaceuticals against hyperlipaemia and atherosclerosis |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0282696B1 (hu) |
JP (2) | JPH0710777B2 (hu) |
KR (1) | KR950009094B1 (hu) |
AT (1) | ATE82125T1 (hu) |
CA (1) | CA1340246C (hu) |
DE (2) | DE3705549A1 (hu) |
DK (1) | DK55888A (hu) |
EG (1) | EG18335A (hu) |
ES (1) | ES2052609T3 (hu) |
GR (1) | GR3006693T3 (hu) |
HU (1) | HUT47850A (hu) |
ZA (1) | ZA88577B (hu) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6740668B1 (en) | 1995-08-28 | 2004-05-25 | Kansas University Medical Center | Methods for inhibiting diabetic complications |
US6228858B1 (en) | 1995-09-12 | 2001-05-08 | University Of Kansas Medical Center | Advanced glycation end-product intermediaries and post-amadori inhibition |
US6716858B1 (en) | 1995-08-28 | 2004-04-06 | Kansas University Medical Center | Methods for inhibiting diabetic complications |
US5744451A (en) | 1995-09-12 | 1998-04-28 | Warner-Lambert Company | N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
US6730686B1 (en) | 1995-09-12 | 2004-05-04 | Kansas University Medical Center | Methods for inhibiting oxidative modification of proteins |
US6750209B1 (en) | 1995-09-12 | 2004-06-15 | Kansas University Medical Center | Advanced glycation end-product intermediaries and post-amadori inhibition |
US7030146B2 (en) | 1996-09-10 | 2006-04-18 | University Of South Carolina | Methods for treating diabetic neuropathy |
US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
WO2000022094A2 (en) * | 1998-10-09 | 2000-04-20 | Kansas University Medical Center | Methods for inhibiting oxidative modification of proteins |
ATE306489T1 (de) | 1999-03-08 | 2005-10-15 | Medicure Inc | Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel |
US6489345B1 (en) | 1999-07-13 | 2002-12-03 | Medicure, Inc. | Treatment of diabetes and related pathologies |
CA2383252A1 (en) | 1999-08-24 | 2001-03-01 | Medicure International Inc. | Treatment of cardiovascular related pathologies |
DE60133323T2 (de) | 2000-02-29 | 2009-03-05 | Medicure International Inc. | Cardioprotektive Phosphonate |
WO2001072309A2 (en) | 2000-03-28 | 2001-10-04 | Medicure International Inc. | Treatment of cerebrovascular disease |
US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
US6897228B2 (en) | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
JP2004502757A (ja) | 2000-07-07 | 2004-01-29 | メディキュア インターナショナル インコーポレイテッド | ピリドキシンおよびピリドキサール類縁体:心血管系治療薬 |
CA2520403A1 (en) * | 2003-03-27 | 2004-10-07 | Medicure Inc. | Modulation of cell death |
JP2008517956A (ja) | 2004-10-28 | 2008-05-29 | メディキュア・インターナショナル・インコーポレーテッド | 二重の抗血小板性/抗凝固性ピリドキシン類似体 |
CA2593793A1 (en) * | 2005-01-05 | 2006-07-13 | Medicure International Inc. | Compounds and methods for regulating triglyceride levels |
FR3038227B1 (fr) * | 2015-06-30 | 2018-08-17 | Assistance Publique - Hopitaux De Paris | Formulation effervescente a base de pyridoxal-5-phosphate |
WO2020003363A1 (ja) * | 2018-06-25 | 2020-01-02 | 学校法人近畿大学 | ニコチン摂取の影響による血管の劣化を防止するための健康食品または医薬組成物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3373E (fr) | 1904-02-26 | 1904-10-27 | Joseph Louis Felix Garrigou | Procédé de traitement des vidanges et déchets organiques, et appareil d'ensemble permettant sa mise en oeuvre |
FR6707M (hu) * | 1966-04-29 | 1969-02-17 | ||
GB1070120A (en) * | 1966-05-06 | 1967-05-24 | Tanabe Seiyaku Co | Pyridoxine derivative and the preparation thereof |
FR7238M (hu) * | 1968-03-27 | 1969-09-01 | ||
FR2035765A1 (en) | 1969-03-06 | 1970-12-24 | Inst Rech Scient | Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates |
JPS5347110B2 (hu) * | 1971-11-02 | 1978-12-19 | ||
FR2176509A2 (en) | 1972-03-21 | 1973-11-02 | Inst Rech Scient | Pyridoxine p-chlorophenoxyisobutyrate prodn - giving very pure product from corresp acid and pyridoxine |
JPS5018470A (hu) * | 1973-05-31 | 1975-02-26 | ||
FR2260330A1 (en) | 1974-02-07 | 1975-09-05 | Innothera Lab Sa | Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index |
CH607773A5 (en) | 1974-12-24 | 1978-10-31 | Steigerwald Arzneimittelwerk | Process for the preparation of novel pyridoxine derivatives |
DE2461742C2 (de) * | 1974-12-28 | 1983-01-27 | Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt | Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
FR2349330A1 (fr) * | 1976-04-29 | 1977-11-25 | Savini Emile | Composition destinee au traitement des hyperlipidemies |
JPS5347110A (en) * | 1976-10-12 | 1978-04-27 | Osaka Bosui Kensetsusha Kk | Impermeable wall forming method |
-
1987
- 1987-02-18 DE DE19873705549 patent/DE3705549A1/de not_active Withdrawn
-
1988
- 1988-01-20 ES ES88100747T patent/ES2052609T3/es not_active Expired - Lifetime
- 1988-01-20 AT AT88100747T patent/ATE82125T1/de not_active IP Right Cessation
- 1988-01-20 DE DE8888100747T patent/DE3875760D1/de not_active Expired - Fee Related
- 1988-01-20 EP EP88100747A patent/EP0282696B1/de not_active Expired - Lifetime
- 1988-01-28 ZA ZA880577A patent/ZA88577B/xx unknown
- 1988-02-01 EG EG53/88A patent/EG18335A/xx active
- 1988-02-03 DK DK055888A patent/DK55888A/da not_active Application Discontinuation
- 1988-02-16 HU HU88723A patent/HUT47850A/hu unknown
- 1988-02-17 KR KR1019880001692A patent/KR950009094B1/ko not_active IP Right Cessation
- 1988-02-17 JP JP63032943A patent/JPH0710777B2/ja not_active Expired - Lifetime
- 1988-02-18 CA CA000559285A patent/CA1340246C/en not_active Expired - Fee Related
-
1992
- 1992-12-28 GR GR920403159T patent/GR3006693T3/el unknown
-
1994
- 1994-09-02 JP JP6209830A patent/JP2588686B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS63203621A (ja) | 1988-08-23 |
JPH0710777B2 (ja) | 1995-02-08 |
EP0282696A3 (en) | 1989-06-14 |
DE3875760D1 (de) | 1992-12-17 |
JPH07238020A (ja) | 1995-09-12 |
ZA88577B (en) | 1988-07-28 |
GR3006693T3 (hu) | 1993-06-30 |
EP0282696B1 (de) | 1992-11-11 |
JP2588686B2 (ja) | 1997-03-05 |
EG18335A (en) | 1992-09-30 |
ES2052609T3 (es) | 1994-07-16 |
CA1340246C (en) | 1998-12-15 |
ATE82125T1 (de) | 1992-11-15 |
DE3705549A1 (de) | 1988-09-01 |
KR880009649A (ko) | 1988-10-04 |
KR950009094B1 (ko) | 1995-08-14 |
DK55888A (da) | 1988-08-19 |
DK55888D0 (da) | 1988-02-03 |
EP0282696A2 (de) | 1988-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT47850A (en) | Process for producing pharmaceuticals against hyperlipaemia and atherosclerosis | |
HUT44706A (en) | Process for stabilizing hormones of growth | |
IL109604A0 (en) | Substituted mono- and bipyridylmethyl- pyridones, process for their preparation and pharmaceutical compositions containing them | |
CA2006267A1 (en) | Method of treating herpesviruses | |
HUT45564A (en) | Process for producing hirudine variants | |
AU1099488A (en) | Wood treatment composition and process | |
HK217196A (en) | Diamine salts of clavulanic acid | |
EP0285856A3 (en) | Use of dihydroergotamine and its salts in the local treatment of trophic disorders | |
AU1463888A (en) | Nitrification-inhibiting agent | |
GR3005222T3 (hu) | ||
AU7071487A (en) | Chlorpheniramine therapy | |
AU589148B2 (en) | Medicament for the treatment of acquired immune deficiency syndrome and corresponding pharmaceutical compositions and method of treatment | |
EP0286802A3 (en) | Use of ofloxacin in treating or preventing locally periodontal disease | |
GR3003880T3 (hu) | ||
AU1691888A (en) | Compound active in cardiovascular therapy | |
DE3466877D1 (en) | Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process | |
UA7403A1 (uk) | Спосіб приготування живильного середовища для культивування продуцентів l-лізіну | |
AU1732888A (en) | Stable 5-fluorouracil compositions | |
ES8706695A1 (es) | Procedimiento para la fabricacion de compuestos hidroximetilcefem | |
HUT47092A (en) | Process for producing thiadiazol derivatives and pharmaceutical compositions containing them as active components | |
HU912018D0 (en) | Process for the production of (1,4)diazepino (3,4-b)kinasolyne-3,7-dion derivatives and their medicative salts, and process for the production of medical products containing the active agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFC9 | Refusal of application |